Painless: The Case of Too Much Anandamide

When it comes to pain it looks like you can’t have too much Anandamide. Anandamide, aka “the bliss molecule”, or N-arachidonoylethanolamine (AEA) is an endogenous cannabinoid produced by the human body that binds to the endocannabinoid system similar to plant-derived THC. Anandamide, the "Bliss Molecule" Recently an article appeared in the British Journal of Anesthesia that discussed an unusual case of a woman who felt little or no pain. When the case came to the attention of researchers, what they found provides us with more insight regarding the analgesic and anxiolytic effects not o...
More

Commentary: Endorsing Cannabis as an Opioid Substitute ‘Irresponsible’

This is yet another piece of propaganda in the counter-attack by Big Pharma/FDA/DEA on our progress. So sad, so stereotypical and so mistaken. I am really embarrassed by this endless repetition of falsehoods and circular reasoning. I think we have to call it for what it is, push forward the recent World Health Organization recommendations for rescheduling to lowest category possible, which would facilitate better research on safer alternatives that could end this epidemic. Anything else is what is irresponsible. -Dr. David Ostrow Endorsing Cannabis as an Opioid Substitute 'Irresponsibl...
More

Commentary: Could cannabis be key to combat the opioid crisis?

This is an interesting review based on U.S. experience, but proposing the use of cannabis to treat pain and opiate misuse in Australia, which has the second-highest rate of opioid analgesic use in the world. This highlights the important of reviews by highlighting the potential for good in cotnrast to the counter attack highlighting potential negative consequences. Not bad for a commercial online publication, I say.-Dr. David Ostrow Could cannabis be key to combat the opioid crisis? by Zoe Gross for FinFeed Weed’s legal forays began in the medical space as a way to treat chronic...
More